Logo

Take That

Jul 20, 2009

After worries that their data for their experimental lupus drug wouldn't be up to snuff, Human Genome Sciences is vindicated. According to Bloomberg, Benlysta met the goals of its clinical study, finding that it "was more effective at easing pain, hair loss and skin rash than a placebo." This report sent the company's stock upwards by 200 percent from to $10.01, reports MarketWatch this morning.

Breaking News
The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.